Bicara Therapeutics Inc. (BCAX) stock

BCAXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30

$10.11−0.42 (-3.99%)

Close on Nov 12, 2026Market cap $669.01MP/E –Yield –

Bicara Therapeutics statistics

64 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Mar 29, 2027 (estimated, before the open)
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 12, 2026

Valuation ratiosIndustry

Market Cap: $669.01M; $280.48M
Enterprise Value: $226.66M; $148.62M
PB Ratio: 1.63; 2.05
P/TBV Ratio: 1.63; 2.29

Share statisticsIndustry

Shares Outstanding: 66M; 58M
Shares Change (QoQ): 0.64%; 0.51%
Float: 49M; 49M
Shares Held by Insiders: 25.7%; 12.1%
Shares Held by Institutions: 105.5%; 56.4%

Short sellingIndustry

Short Interest: 10M; –
Short Interest Change: -4.24%; -0.76%
Short % of Float: 20.1%; 9.04%
Short % of Shares Outstanding: 14.9%; 6.30%
Days to Cover: 3.84; 5.13

Stock price statisticsIndustry

52-Week High: $30.99; –
52-Week Low: $7.87; –
20-Day Moving Average: $12.58; –
50-Day Moving Average: $17.10; –
200-Day Moving Average: $20.87; –
Average True Range (14): $1.30; –
Price Change (1 Week): 23.4%; 1.51%
Price Change (1 Month): -41.7%; -2.35%
Price Change (3 Months): -58.4%; -21.1%
Price Change (6 Months): -51.0%; -22.6%
Price Change (YTD): -39.9%; -22.6%
Price Change (1 Year): -31.4%; -20.7%
Average Volume (10 Days): 2M; –
Average Volume (20 Days): 2M; –
Average Volume (90 Days): 990,067; –
Relative Volume: 1.93; 0.79
Relative Strength Index (14): 34.5; 44.7
Volatility (1 Year): 73.6%; 80.4%
Beta (5 Years): 1.59; 1.07

Returns on capitalIndustry

Return on Equity (ROE): -54.2%; -51.2%
Return on Assets (ROA): -49.8%; -40.6%
Return on Invested Capital (ROIC): -470.0%; -32.9%
Return on Capital Employed (ROCE): -57.9%; -38.0%

Financial positionIndustry

Current Ratio: 8.81; 3.30
Quick Ratio: 8.63; 2.42

EfficiencyIndustry

Profits Per Employee: -$2.14M; -$683.67K
Employee Count: 103; 75
WACC: 12.9%; 10.1%

Income statement (TTM)Industry

Operating Income: -$237.03M; -$20.99M
Pretax Income: -$220.06M; -$13.23M
Net Income: -$220.28M; -$21.61M
EBITDA: -$237.03M; -$16.85M

Balance sheetIndustry

Cash & Short-Term Investments: $442.35M; $67.63M
Net Cash (Debt): $442.35M; $17.46M
Net Cash Per Share: $6.68; $0.72
Equity (Book Value): $409.41M; $53.27M
Book Value Per Share: $6.19; $1.50
Tangible Book Value: $409.41M; $26.82M
Working Capital: $400.18M; $79.47M

Cash flow (TTM)Industry

Operating Cash Flow: -$161.73M; -$12.27M
Capital Expenditures: -$1.02M; -$944.00K
Free Cash Flow: -$162.75M; -$18.20M
FCF Per Share: -$2.46; -$0.42

Dividends and yieldsIndustry

Earnings Yield: -32.9%; -20.8%
FCF Yield: -24.3%; -9.58%
Buyback Yield: -28.6%; -0.73%
Shareholder Yield: -28.6%; 0.00%

Taxes and interestIndustry

Income Tax: $220.00K; $74.00K

Scores and fair valueIndustry

Altman Z-Score: 5.53; 0.30
Piotroski F-Score: 2; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

Period	BCAX	S&P 500	Difference
1 month	-41.7%	-2.7%	−39.0 pts
3 months	-59.0%	-1.7%	−57.2 pts
Year to date	-39.9%	+11.9%	−51.8 pts
1 year	-32.2%	+12.0%	−44.2 pts

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

10M BCAX shares were sold short on Oct 30, 2026, down 4.2% from the previous report, or 20.06% of the shares available to trade. At recent volumes it would take 3.8 days to buy them back. Over the last 20 sessions, 33.6% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	9,861,807	-4.2%	2,570,859	3.8
Oct 15, 2026	10,298,207	-3.7%	893,322	11.5
Sep 30, 2026	10,693,490	-4.5%	753,208	14.2
Sep 15, 2026	11,191,724	+3.2%	496,027	22.6
Aug 31, 2026	10,845,514	+3.7%	491,104	22.1
Aug 14, 2026	10,463,188	+9.0%	787,826	13.3
Jul 31, 2026	9,597,404	+3.0%	469,965	20.4
Jul 15, 2026	9,315,906	-8.0%	734,248	12.7
Jun 30, 2026	10,121,649	-0.4%	1,379,948	7.3
Jun 15, 2026	10,160,393	+0.8%	514,104	19.8
May 29, 2026	10,083,302	+2.4%	448,419	22.5
May 15, 2026	9,849,290	+10.7%	568,908	17.3

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?